[New bone density conservation agents for osteoporosis under research and development: Anti-RANKL antibody].

Subjects

Subjects :

Antibodies, Monoclonal pharmacology
Antibodies, Monoclonal, Humanized
Bone Density
Bone Remodeling
Bone Resorption
Bone and Bones metabolism
Cell Differentiation
Clinical Trials as Topic
Denosumab
Humans
Osteoclasts cytology
Osteoclasts physiology
Osteoporosis, Postmenopausal complications
Osteoporosis, Postmenopausal metabolism
RANK Ligand pharmacology
RANK Ligand physiology
RANK Ligand therapeutic use
Antibodies, Monoclonal therapeutic use
Drug Design
Osteoporosis, Postmenopausal drug therapy
RANK Ligand immunology

Details

Language :

Japanese

ISSN :

0047-1852

Volume :

65 Suppl 9

Database :

MEDLINE

Journal :

Nihon rinsho. Japanese journal of clinical medicine

Publication Type :

Academic Journal

Accession number :

18161149